Beigene Ltd
SSE:688235

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
SSE:688235
Watchlist
Price: 163.53 CNY 0.7%
Market Cap: 145.9B CNY
Have any thoughts about
Beigene Ltd?
Write Note

Relative Value

The Relative Value of one Beigene Ltd stock under the Base Case scenario is 301.82 CNY. Compared to the current market price of 163.53 CNY, Beigene Ltd is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
301.82 CNY
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
49
Median 3Y
9.2
Median 5Y
9.2
Industry
7.6
Forward
5.5
vs History
vs Industry
Median 3Y
-10.6
Median 5Y
-10.6
Industry
22.1
Forward
-35.4
vs History
vs Industry
Median 3Y
-14.9
Median 5Y
-14.9
Industry
21.9
vs History
vs Industry
Median 3Y
-11.1
Median 5Y
-11.1
Industry
23.4
vs History
7
vs Industry
12
Median 3Y
4.2
Median 5Y
4.2
Industry
2.5
vs History
73
vs Industry
43
Median 3Y
7.5
Median 5Y
7.5
Industry
7.5
Forward
5.1
vs History
73
vs Industry
39
Median 3Y
9
Median 5Y
9
Industry
9.3
vs History
vs Industry
Median 3Y
-8.9
Median 5Y
-8.9
Industry
4.2
Forward
-33.7
vs History
vs Industry
Median 3Y
-8.9
Median 5Y
-8.9
Industry
4
Forward
-27.5
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-11.6
Industry
5.9
vs History
vs Industry
Median 3Y
-8.4
Median 5Y
-8.4
Industry
3.9
vs History
31
vs Industry
20
Median 3Y
6.3
Median 5Y
6.3
Industry
4.5

Multiples Across Competitors

Competitors Multiples
Beigene Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KY
Beigene Ltd
SSE:688235
145.9B CNY 6.2 -22.4 -20.7 -20.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 059 457.3 -180 891 -219 659.2 -217 152.6
US
Abbvie Inc
NYSE:ABBV
316.7B USD 5.7 62.3 15.5 23.8
US
Amgen Inc
NASDAQ:AMGN
141.5B USD 4.3 33.4 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
117.6B USD 4.2 933.6 10.4 10.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.8B USD 10 -220.6 21.8 22.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 851 -472.3 -514.4 -500.7
AU
CSL Ltd
ASX:CSL
136.4B AUD 5.7 32.1 19.9 24.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD 5.7 17 15.4 17.1
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.7 -53
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.4 -136.1 -109.9 -80.1
P/S Multiple
Revenue Growth P/S to Growth
KY
Beigene Ltd
SSE:688235
Average P/S: 3 460 126.1
6.2
122%
0.1
FR
Pharnext SCA
OTC:PNEXF
38 059 457.3
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.3
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.2
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
34%
0.3
US
E
Epizyme Inc
F:EPE
1 851
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.4
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
KY
Beigene Ltd
SSE:688235
Average P/E: 215.7
Negative Multiple: -22.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 891 N/A N/A
US
Abbvie Inc
NYSE:ABBV
62.3
413%
0.2
US
Amgen Inc
NASDAQ:AMGN
33.4
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
933.6
77%
12.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -220.6
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.3 N/A N/A
AU
CSL Ltd
ASX:CSL
32.1
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KY
Beigene Ltd
SSE:688235
Average EV/EBITDA: 16.5
Negative Multiple: -20.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 659.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.8
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.4 N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -109.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KY
Beigene Ltd
SSE:688235
Average EV/EBIT: 21.6
Negative Multiple: -20.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 152.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.8
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.7 N/A N/A
AU
CSL Ltd
ASX:CSL
24.8
54%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -80.1 N/A N/A

See Also

Discover More
Back to Top